Vedanta Capital
Fund of fundsNew York · Seed–Late Stage · 9 people tracked
Investment thesis
Vedanta Capital operates as an allocator offering limited partners access to venture capital and growth equity. Its funds of funds give institutions and individuals exposure to leading VC and growth equity funds, while its direct funds provide LPs direct access to venture- and growth-stage companies. The firm frames its mission around investing, empowering, and innovating.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website
What they invest in
from 14 of 49 portfolio companiesBiotech ×8Healthtech ×4AI & Machine Learning ×2Cybersecurity ×2Medical Devices ×2Wellness & Fitness ×2B2B Marketplaces ×1Consumer ×1
HQs:United States×10India×2
Investments · 49 tracked
founders shown can be your intro pathBiotechnology company developing and commercializing immunotherapy products for cancer
BiotechBethesda, US
Linda F Powers(Executive Officer, Director)Navid Malik(Director)Marnix Bosch(Executive Officer)Jerry Jasinowski(Director)Leslie Goldman(Executive Officer)J Cofer Black(Director)
Clinical-stage pharmaceutical company developing innovative therapies
BiotechSanta Clara, US
Laxminarayan Bhat(Executive Officer, Director)Marc Cantillon(Executive Officer)Sarvajna Dwivedi(Director)Pedr Jensen(Director)Purav Patel(Director)Narayan Prabhu(Executive Officer)
Optical telecommunications equipment provider
Electronic Design Automation software for complex chip design
Axiado develops AI-driven, hardware-anchored platform security processors (its TCU chip) embedded in servers, 5G, network, and power management controller infrastructure.
CybersecurityHardwareSemiconductorsSan Jose, US
Ashok Babbar(Executive Officer, Director)Axel K. Kloth(Executive Officer, Director)David F. Welch(Director)
Developer and manufacturer of medical technologies for respiratory and neuromuscular diseases
Indian café chain operating in six countries
Virtual reality telerobotics platform
Pharmaceutical company developing novel approach to Alzheimer's disease
BiotechNew York, US
Adrian N. Hobden(Executive Officer, Director)Daniel G. Chain(Executive Officer, Director)Samuel Jesselson(Director)Michael Jesselson(Director)
Retailer of consumer electronics and technology products
Cloud-based healthcare analytics solutions
Trusted partner for specialty chemicals
Epikast provides medically trained talent and AI-driven engagement tools to biopharma and healthcare organizations for communicating with healthcare professionals and patients across the US and Europe.
AI & Machine LearningHealthtechBrooklyn, US
Evangelos Vergetis(Executive Officer, Director)
BoardOleg Nodelman(Director)Brad Prosek(Director)Stelios Papadopoulos(Director)Daphne Karydas(Director)Alexandros Tzoukas(Director)
Mall-based clothing retailer for teenagers
Company focusing on genetic research in cancer detection
Immuneel develops and delivers cell and gene therapies, including CAR-T cell therapy, to treat cancer patients in India and beyond.
BiotechHealthtech
Solutions provider for intelligence, cyber and counterterrorism communities
Small business lending platform using cutting-edge technologies and automation
Global medical technology company developing patient monitoring technologies
Prepaid wireless service provider
Supplier of bioanalytical measurement systems for drug discovery and life sciences research
Clinical-stage oncology company developing cancer treatments
BiotechDel Mar, US
Dana McGowan(Treasurer and Secretary)Karen Lundgren(Vice President and Chief Scientific Officer)Lauren G. Otsuki(Chief Business Officer)James Freddo(Chief Medical Officer)David F. Hale(Director)Scott Glenn(Director)
Developer of optical telecommunications systems
Life sciences consulting firm and contract research organization
Multinational corporation developing video, voice and content collaboration and communication technology
Chicago, US
PRABHAKANT SINHA(Executive Officer, Director)ROSHAN ALVARES(Executive Officer, Director)SANGA REDDY PEERREDDY(Executive Officer, Director)
Semiconductor company developing proprietary mixed-signal integrated circuits
Socrates Health Solutions develops non-invasive blood glucose monitoring devices for individuals managing diabetes, designed to eliminate needle insertion and finger pricks while providing real-time glucose tracking and predictive alerts.
Digital HealthHealthtechMedical DevicesDallas, US
Scott Smith(CEO, Founder and Board Member)Sharon Gregory(VP Operations)Michael Gorton(Board Member)Douglas Sutherland(Chairman of the Board)Patrick Kinder(Board Member)Tommy Thompson(Director)
Aviation and aerospace company reducing space travel costs through reusable rockets
Biopharmaceutical company developing innovative immunotherapies for tauopathies
BiotechLondon
Daniel Chain(Executive Officer, Director)Andrew Heath(Director)Shafique Virani(Director)John Gogol(Director)
BoardParag Saxena(Director)
Next-generation gigabit router provider
Ulta Beauty is an international specialty beauty retailer offering cosmetics, fragrance, skin care, wellness, hair care products, and salon services from over 600 brands across more than 1,500 locations primarily in the U.S., with additional operations in the U.K., Ireland, Mexico, and the Middle East.
ConsumerRetail TechWellness & FitnessBolingbrook, US
Power management analog and mixed-signal semiconductor company
American women's clothing retailer
Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.
AI & Machine LearningBiotechMedical Devices
Dr. Ci Chu(Chief Discovery Officer)Dr. Bo Wang(Chief AI Scientist)Dr. Ian McCaffery(SVP, Translational Science and Early Clinical Development)
Exits · 5
IPOs and acquisitions across the tracked portfolioAlkermesNASDAQ: ALKSBicara TherapeuticsNASDAQ: BCAXNorthwest BiotherapeuticsOTC: NWBOReviva PharmaceuticalsOTC: RVPHStarbucksNASDAQ: SBUX
Portfolio news
latest coverage across their companiesUlta Salon Cosmetics Fragrance · ad-hoc-news.de · Jul 19, 2026
Xaira Therapeutics · thenextweb.com · Jul 15, 2026
Frequently asked questions
- What stage does Vedanta Capital invest at?
- Vedanta Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Vedanta Capital focus on?
- Vedanta Capital focuses on Sector Agnostic.
- Where is Vedanta Capital located?
- Vedanta Capital is headquartered in New York, US.
Similar investors
Insight Partners is a venture and growth-stage software investor featuring a large portfolio of technology companies across multiple sectors and regions.
ATEL Ventures is the venture debt arm of ATEL Capital Group, which owns and manages a portfolio of leased equipment, loans to high-growth companies, and real estate. It lends growth capital to high-growth businesses across sectors and stages.
Plaza Ventures is a Canadian investment firm focused on scaling technology companies through primary and secondary investments, spanning venture capital, private equity, and opportunistic strategies.
Cambium Grove Capital (CGC) is a multi-strategy investment firm deploying capital across venture and growth equity, real estate, and special situations, and can invest throughout the capital structure.